These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea. Williams DJ; Jensen SD; Nimorakiotakis B; Müller R; Winkel KD Toxicon; 2007 May; 49(6):780-92. PubMed ID: 17210167 [TBL] [Abstract][Full Text] [Related]
66. Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria. Abubakar IS; Abubakar SB; Habib AG; Nasidi A; Durfa N; Yusuf PO; Larnyang S; Garnvwa J; Sokomba E; Salako L; Theakston RD; Juszczak E; Alder N; Warrell DA; PLoS Negl Trop Dis; 2010 Jul; 4(7):e767. PubMed ID: 20668549 [TBL] [Abstract][Full Text] [Related]
67. A randomized, double-blind, placebo-controlled trial of antivenom for local effects of green pit viper bites. Rojnuckarin P; Chanthawibun W; Noiphrom J; Pakmanee N; Intragumtornchai T Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):879-84. PubMed ID: 16466758 [TBL] [Abstract][Full Text] [Related]
68. Comparison of Pasteur and Behringwerke antivenoms in envenoming by the carpet viper (Echis carinatus). Warrell DA; Warrell MJ; Edgar W; Prentice CR; Mathison J; Mathison J Br Med J; 1980 Mar; 280(6214):607-9. PubMed ID: 7370603 [TBL] [Abstract][Full Text] [Related]
70. Low dose of snake antivenom is as effective as high dose in patients with severe neurotoxic snake envenoming. Agarwal R; Aggarwal AN; Gupta D; Behera D; Jindal SK Emerg Med J; 2005 Jun; 22(6):397-9. PubMed ID: 15911942 [TBL] [Abstract][Full Text] [Related]
71. Clinical studies of the effectiveness and safety of antivenoms. Williams DJ; Habib AG; Warrell DA Toxicon; 2018 Aug; 150():1-10. PubMed ID: 29746978 [TBL] [Abstract][Full Text] [Related]
72. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom. Meyer WP; Habib AG; Onayade AA; Yakubu A; Smith DC; Nasidi A; Daudu IJ; Warrell DA; Theakston RD Am J Trop Med Hyg; 1997 Mar; 56(3):291-300. PubMed ID: 9129531 [TBL] [Abstract][Full Text] [Related]
73. Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product--'what's in a name?'. Warrell DA Trans R Soc Trop Med Hyg; 2008 May; 102(5):397-9. PubMed ID: 18359053 [TBL] [Abstract][Full Text] [Related]
74. Life-threatening envenoming by the Saharan horned viper (Cerastes cerastes) causing micro-angiopathic haemolysis, coagulopathy and acute renal failure: clinical cases and review. Schneemann M; Cathomas R; Laidlaw ST; El Nahas AM; Theakston RD; Warrell DA QJM; 2004 Nov; 97(11):717-27. PubMed ID: 15496528 [TBL] [Abstract][Full Text] [Related]
75. [Envenomation by exotic snakes]. Aubert M; De Haro L; Jouglard J Med Trop (Mars); 1996; 56(4):384-92. PubMed ID: 9139199 [TBL] [Abstract][Full Text] [Related]
76. Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria. Habib AG; Lamorde M; Dalhat MM; Habib ZG; Kuznik A PLoS Negl Trop Dis; 2015 Jan; 9(1):e3381. PubMed ID: 25569252 [TBL] [Abstract][Full Text] [Related]
77. Comparison of the neurotoxic and myotoxic effects of Brazilian Bothrops venoms and their neutralization by commercial antivenom. Zamunér SR; da Cruz-Höfling MA; Corrado AP; Hyslop S; Rodrigues-Simioni L Toxicon; 2004 Sep; 44(3):259-71. PubMed ID: 15302532 [TBL] [Abstract][Full Text] [Related]
78. [The management of snake envenomation: evaluation of twenty-one snake bite cases]. Köse R Ulus Travma Acil Cerrahi Derg; 2007 Oct; 13(4):307-12. PubMed ID: 17978913 [TBL] [Abstract][Full Text] [Related]